Bendixen, Kamilla Kolding http://orcid.org/0000-0002-6586-6724
Mindegaard, Maria http://orcid.org/0009-0000-7114-7622
Epistolio, Samantha http://orcid.org/0000-0003-1236-2722
Dazio, Giulia
Marchi, Francesco http://orcid.org/0000-0001-6532-7168
Spina, Paolo http://orcid.org/0000-0002-9204-1410
Arnspang, Eva C.
Soerensen, Mette http://orcid.org/0000-0001-5268-3366
Christensen, Ulf Bech http://orcid.org/0000-0003-4777-1972
Frattini, Milo
Petersen, Rasmus Koefoed
Funding for this research was provided by:
Innovationsfonden (1044-00027B)
EC | Eurostars (E! 12513, E! 12513, E! 12513, E! 12513, E! 12513)
Article History
Received: 28 March 2023
Accepted: 14 August 2023
First Online: 24 August 2023
Competing interests
: K.K.B., M.M., R.K.P. and U.B.C. were employed at PentaBase A/S during the study who is a manufacturer and seller of EpiDirect® MGMT Methylation qPCR Assay utilized in this study. U.B.C. and R.K.P. are co-owners of PentaBase A/S. K.K.B., U.B.C. and R.K.P. are all founders of a patent application covering the technology utilized in this study [International Publication number: WO2022002958]. The remaining authors declare no competing interests.